Key points are not available for this paper at this time.
Comorbidities shape HF progression in observational data; leaves open whether targeting them alters outcomes in prospective trials.
The syndrome of chronic heart failure is a systemic disease state with primary cardiac dysfunction that subsequently affects multiple organ systems. After the primary cardiac insult, the clinical course of the patient is affected by comorbidities and the underlying type of cardiomyopathy. The most common cause of heart failure in the United States is coronary artery disease. This proportion is rising due to improved survival of patients after myocardial infarction secondary to the success of coronary revascularization procedures but also because of the increasing number of patients with cardiac risk factors such as obesity, diabetes, hypertension, and hyperlipidemia.
No takes yet. Share an insight, caveat, or question.
P. Christian Schulze (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: